Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Wh Vangilst"'
Publikováno v:
Journal of the American College of Cardiology. 30:400-405
Objectives. This study was conducted to test the hypothesis that angiotensin-converting enzyme (ACE) inhibition reduces myocardial ischemia and related events after myocardial infarction (MI). Background. The oxygen demand/supply ratio of the myocard
Autor:
Wh Vangilst, Jh Kingma
Publikováno v:
Journal of Cardiovascular Pharmacology. 19:S13-S17
Restoration of coronary blood flow in the ischemic myocardium is necessary to prevent irreversible cellular damage, although it may result in hazardous consequences. Because thrombolysis during myocardial infarction is designed to salvage a maximal n
Publikováno v:
Journal of Cardiovascular Pharmacology. 15:884-891
Efficacy of flecainide was investigated in 50 patients with sustained ventricular tachycardia (n = 38) or ventricular fibrillation (n = 12) during a 4-week in-hospital and 1-year follow-up period. Furthermore, the predictive value of programmed elect
Autor:
JG Grandjean, A vanBuiten, M Oosterga, Wh Vangilst, Hendrik Buikema, JF May, Adriaan A. Voors
Publikováno v:
Cardiovascular Research, 34(3), 568-574. Oxford University Press
Objective: Impairment of endothelium-dependent relaxation is related to dyslipidemia and may be an early marker for atherosclerosis in angiographically smooth arteries. The aim of the present study was to relate preoperative serum lipids to endotheli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b07e1f0d4f6e558b692640e79c52cb2
https://research.rug.nl/en/publications/d2979b9c-cc3a-44a9-a5cb-cb883f18290b
https://research.rug.nl/en/publications/d2979b9c-cc3a-44a9-a5cb-cb883f18290b
Autor:
Harry Wesseling, Pa Degraeff, Hans L. Hillege, Ki Lie, Wh Vangilst, Saj Vandenbroek, A Vanbruggen
Publikováno v:
Journal of cardiovascular pharmacology. 18(4)
The acute hemodynamic, hormonal, and pharmacokinetic responses to the oral angiotensin-converting enzyme (ACE) inhibitor spirapril were studied in 15 patients with moderate to severe congestive heart failure in a baseline controlled dose-ranging stud
Publikováno v:
The American journal of cardiology. 68(4)
The sequential use of different types of antiarrhythmic drugs may improve arrhythmia prognosis in chronic atrial fibrillation or flutter after successful electrical cardioversion. The rationale for serial treatment is that the arrhythmogenic mechanis
Autor:
Jh Kingma, Wh Vangilst
Publikováno v:
Journal of Molecular and Cellular Cardiology. 24:S19
Publikováno v:
Journal of Cardiovascular Pharmacology. 20:337
The adjunctive use of angiotensin-converting enzyme (ACE) inhibitors with thrombolytic therapy early during acute myocardial infarction offers theoretic advantages. In the acute phase, captopril may scavenge free radicals, blunt the catecholamine res
Publikováno v:
Clinical Cardiology, 11(5), 353-355. Wiley
Flecainide is well absorbed after oral administration. Following rapid infusion of flecainide, there is a short distribution phase. Plasma levels of flecainide are proportional to dose. Both QRS durations and flutter wave intervals are lengthened aft
Publikováno v:
European heart journal. 9(6)
The efficacy and safety of oral (up to 400 mg in 3 h) and intravenous regimens (up to 150 mg in 10 min) of flecainide acetate were compared in the acute conversion of atrial fibrillation to sinus rhythm. Acute conversion was defined as conversion occ